熱門資訊> 正文

Affimed报告第一季度业绩

2024-06-12 18:39

Affimed(AFMD) 0

Affimed press release (NASDAQ:AFMD): Q1 total revenue was €0.2 million compared with €4.5 million for the quarter ended March 31, 2023.
Net loss was €19.2 million, or €1.27 loss per common share.

More on Affimed

Affimed: AFM24's Update Was Good, Acimtamig's Should Be Better
Affimed N.V. (AFMD) Q4 2023 Earnings Call Transcript
Affimed gets FDA fast track status for AFM24 for EGFR lung cancer
Seeking Alpha’s Quant Rating on Affimed
Historical earnings data for Affimed

推薦文章

風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。